[go: up one dir, main page]

HUP9901411A2 - Aktív sündisznófehérje konjugátum, eljárás ennek előállítására és felhasználása - Google Patents

Aktív sündisznófehérje konjugátum, eljárás ennek előállítására és felhasználása

Info

Publication number
HUP9901411A2
HUP9901411A2 HU9901411A HUP9901411A HUP9901411A2 HU P9901411 A2 HUP9901411 A2 HU P9901411A2 HU 9901411 A HU9901411 A HU 9901411A HU P9901411 A HUP9901411 A HU P9901411A HU P9901411 A2 HUP9901411 A2 HU P9901411A2
Authority
HU
Hungary
Prior art keywords
hedgehog protein
hedgehog
calcareous
hydrophobic
production
Prior art date
Application number
HU9901411A
Other languages
English (en)
Inventor
Angelika Esswein
Kurt Lang
Petra Rüger
Tilmann Seytter
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98107911A external-priority patent/EP0953575A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of HU9901411D0 publication Critical patent/HU9901411D0/hu
Publication of HUP9901411A2 publication Critical patent/HUP9901411A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya sündisznófehérje-kőnjűgátűm, amely a) 10-30hidrőfób aminősavból és/vagy transzmembrán csavarvőnalakat képező éspőzítív töltésű aminősavból felépített pőlipeptidet, b) egy-négyalifás, telített vagy telítetlen, 10-24 szénatőm lánchősszúságú éshidrőfób szénhidrőgén-maradékőt, vagy c) a sündisznófehérjéhezkővalens kötéssel kapcsőlódó hidrőfób tiővegyületet tartalmaz. Atalálmány szerinti sündisznó-kőnjűgátűm a módősítatlansündisznófehérjéhez viszőnyítva többszörösen megnövekedett aktivitástműtat. A találmány szerinti sündisznó-kőnjűgátűm a gyógyászatbanalkalmazható. ŕ
HU9901411A 1998-04-30 1999-04-28 Aktív sündisznófehérje konjugátum, eljárás ennek előállítására és felhasználása HUP9901411A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98107911A EP0953575A1 (de) 1998-04-30 1998-04-30 Aktives Hedgehog-Protein-Konjugat, Verfahren zur Herstellung und Verwendung
EP98116733 1998-09-03

Publications (2)

Publication Number Publication Date
HU9901411D0 HU9901411D0 (en) 1999-07-28
HUP9901411A2 true HUP9901411A2 (hu) 1999-12-28

Family

ID=26149214

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901411A HUP9901411A2 (hu) 1998-04-30 1999-04-28 Aktív sündisznófehérje konjugátum, eljárás ennek előállítására és felhasználása

Country Status (18)

Country Link
US (4) US6468978B1 (hu)
EP (2) EP1557427A3 (hu)
JP (1) JP3433136B2 (hu)
KR (1) KR19990083621A (hu)
CN (1) CN1233616A (hu)
AT (1) ATE308563T1 (hu)
AU (1) AU719797B2 (hu)
CA (1) CA2269221A1 (hu)
CY (1) CY1105683T1 (hu)
DE (1) DE69928040T2 (hu)
DK (1) DK0953576T3 (hu)
ES (1) ES2252886T3 (hu)
HU (1) HUP9901411A2 (hu)
IL (1) IL129620A (hu)
MA (1) MA26625A1 (hu)
NO (1) NO992090L (hu)
NZ (1) NZ335385A (hu)
SG (1) SG80028A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2312009A1 (en) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EP1557427A3 (en) * 1998-04-30 2005-10-19 Curis, Inc. Hedgehog protein conjugate
DE69928472T2 (de) 1998-08-07 2006-08-10 Curis, Inc., Cambridge Stabilisierte pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
CA2352570A1 (en) * 1998-12-03 2000-06-22 Biogen, Inc. Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
WO2000073337A1 (en) * 1999-06-01 2000-12-07 Biogen, Inc. Polymer conjugates of hedgehog proteins and uses
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
US7573637B2 (en) * 2004-08-03 2009-08-11 Seiko Epson Corporation Intrinsic polarizer and method of manufacturing an intrinsic polarizer
US8669418B2 (en) * 2005-12-22 2014-03-11 Vib Vzw Means and methods for mediating protein interference
US20100316566A1 (en) * 2008-02-27 2010-12-16 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
US20100172889A1 (en) * 2008-12-05 2010-07-08 Catchmark Jeffrey M Degradable biomolecule compositions
US20110086236A1 (en) * 2009-10-13 2011-04-14 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
KR20140038501A (ko) * 2011-06-06 2014-03-28 키네타 원, 엘엘씨 Shk-기초된 제약학적 조성물 및 이들을 제조하고 이용하는 방법
EP4349899A1 (en) 2013-07-26 2024-04-10 The Penn State Research Foundation Polymer compositions and coatings
WO2017095201A1 (ko) * 2015-12-02 2017-06-08 한미약품 주식회사 지방산 유도체를 이용한 단백질 결합체 및 이의 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
EP0513334A4 (en) * 1990-11-30 1993-08-04 Celtrix Laboratories, Inc. Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair
US5789543A (en) * 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
AU704178B2 (en) * 1993-12-30 1999-04-15 Imperial Cancer Research Technology Ltd Vertebrate embryonic pattern-inducing hedgehog-like proteins
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
JP2002503088A (ja) * 1996-10-07 2002-01-29 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 新規ヘッジホッグ由来ポリペプチド
CA2312009A1 (en) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
NZ504752A (en) * 1997-12-03 2002-10-25 Biogen Inc Hydrophobically-modified protein compositions (particularly hedgehog proteins)
EP1557427A3 (en) * 1998-04-30 2005-10-19 Curis, Inc. Hedgehog protein conjugate
DE69928472T2 (de) * 1998-08-07 2006-08-10 Curis, Inc., Cambridge Stabilisierte pharmazeutische Zusammensetzungen von Hedgehog-Proteinen und deren Verwendung
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro

Also Published As

Publication number Publication date
CY1105683T1 (el) 2010-12-22
HU9901411D0 (en) 1999-07-28
EP1557427A2 (en) 2005-07-27
AU2500999A (en) 1999-11-11
SG80028A1 (en) 2001-04-17
US7153836B2 (en) 2006-12-26
DK0953576T3 (da) 2006-03-20
EP1557427A3 (en) 2005-10-19
MA26625A1 (fr) 2004-12-20
KR19990083621A (ko) 1999-11-25
NO992090D0 (no) 1999-04-29
NZ335385A (en) 2000-09-29
US20050148510A1 (en) 2005-07-07
ATE308563T1 (de) 2005-11-15
AU719797B2 (en) 2000-05-18
US20070191274A1 (en) 2007-08-16
ES2252886T3 (es) 2006-05-16
US6468978B1 (en) 2002-10-22
JP3433136B2 (ja) 2003-08-04
CA2269221A1 (en) 1999-10-30
IL129620A0 (en) 2000-02-29
IL129620A (en) 2009-06-15
EP0953576B1 (en) 2005-11-02
US20030139574A1 (en) 2003-07-24
EP0953576A1 (en) 1999-11-03
DE69928040D1 (de) 2005-12-08
NO992090L (no) 1999-11-01
DE69928040T2 (de) 2006-07-27
US6818623B2 (en) 2004-11-16
CN1233616A (zh) 1999-11-03
JP2000053699A (ja) 2000-02-22

Similar Documents

Publication Publication Date Title
HUP9901411A2 (hu) Aktív sündisznófehérje konjugátum, eljárás ennek előállítására és felhasználása
BR0114475A (pt) Célula para a produção de composição de anticorpo
AU2295895A (en) Dosage forms and method for ameliorating male erectile dysfunction
DK1288223T3 (da) Terapeutiske peptidderivater
MXPA02004671A (es) Conjugados de interferon gamma.
IL96549A0 (en) Production of a biologically active protein
DE60141043D1 (de) Rekombinante anti-cd30-antikörper und deren verwendungen
EP1064308A4 (en) METHODS FOR IDENTIFYING INDUCERS AND INHIBITORS OF PROTEOLYTIC ANTIBODIES, AND COMPOSITIONS AND USES THEREOF
HUP0001136A2 (hu) Limfatikus tumorok kezelésére szolgáló gyógyszerkészítmények
ATE212059T1 (de) Methoden zur identifizierung heterofunktionaler fusionsproteine
NZ596984A (en) Compositions and methods for the treatment of tumor of hematopoietic origin
KR980002066A (ko) 변이형 인간 성장호르몬 및 그의 용도
ATE408631T1 (de) Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion
AR016427A1 (es) CONJUGADOS uTILES PARA EL TRATAMIENTO DE CÁNCER DE PRoSTATA, Y UNA COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE.
DK0383599T3 (da) Protein-anticancermiddel
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
BR9612422A (pt) Pseudo-partìculas virais recombinantes, composição, utilização de pseudo-partìculas, e, processo de estimulação in vitro de respostas t citotóxicas de linfócitos provenientes de indivìduos atingidos por infecções virais ou tumorais.
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
BR9903169A (pt) Conjugado de proteìna de ouriço-cacheiro ativa, processo para sua produção e uso
WO2002022657A3 (en) Peptide antagonist of multiple chemokine receptors and uses thereof
WO2000064489A3 (de) Diagnostischer marker für das humanherz
ECSP992937A (es) Conjugados activos de proteina erizo, proceso para su produccion y uso
ES2009280A6 (es) Un metodo para detectar anticuerpos al virus hiv-1 en una muestra.